Karpiński Tomasz M, Ożarowski Marcin, Seremak-Mrozikiewicz Agnieszka, Wolski Hubert, Adamczak Artur
Department of Medical Microbiology, Poznań University of Medical Sciences, Wieniawskiego 3, 61-712 Poznań, Poland.
Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants, National Research Institute, Wojska Polskiego 71b, 60-630 Poznań, Poland.
J Fungi (Basel). 2021 May 5;7(5):360. doi: 10.3390/jof7050360.
Fungi from the genus are very important human and animal pathogens. Many strains can produce biofilms, which inhibit the activity of antifungal drugs and increase the tolerance or resistance to them as well. Clinically, this process leads to persistent infections and increased mortality. Today, many species are resistant to drugs, including , which is a multiresistant pathogen. Natural compounds may potentially be used to combat multiresistant and biofilm-forming strains. The aim of this review was to present plant-derived preparations and compounds that inhibit biofilm formation by at least 50%. A total of 29 essential oils and 16 plant extracts demonstrate activity against biofilms, with the following families predominating: Lamiaceae, Myrtaceae, Asteraceae, Fabaceae, and Apiacae. (0.045-0.07 mg/L), (0.06-8 mg/L), and (2.5 mg/L) have the best antifungal activity. High efficacy has also been observed with , , and . Moreover, 69 plant compounds demonstrate activity against biofilms. Activity in concentrations below 16 mg/L was observed with phenolic compounds (thymol, pterostilbene, and eugenol), sesquiterpene derivatives (warburganal, polygodial, and ivalin), chalconoid (lichochalcone A), steroidal saponin (dioscin), flavonoid (baicalein), alkaloids (waltheriones), macrocyclic bisbibenzyl (riccardin D), and cannabinoid (cannabidiol). The above compounds act on biofilm formation and/or mature biofilms. In summary, plant preparations and compounds exhibit anti-biofilm activity against . Given this, they may be a promising alternative to antifungal drugs.
该属的真菌是非常重要的人类和动物病原体。许多菌株可产生生物膜,这会抑制抗真菌药物的活性,并增加对其的耐受性或耐药性。在临床上,这个过程会导致持续性感染并增加死亡率。如今,许多该属物种对药物具有耐药性,包括多重耐药病原体。天然化合物可能有潜力用于对抗多重耐药和形成生物膜的菌株。本综述的目的是介绍能抑制该属生物膜形成至少50%的植物源制剂和化合物。共有29种精油和16种植物提取物对该属生物膜具有活性,其中以下科占主导:唇形科、桃金娘科、菊科、豆科和伞形科。(0.045 - 0.07毫克/升)、(0.06 - 8毫克/升)和(2.5毫克/升)具有最佳抗真菌活性。在、和中也观察到了高效性。此外,69种植物化合物对该属生物膜具有活性。在低于16毫克/升的浓度下,酚类化合物(百里香酚、紫檀芪和丁香酚)、倍半萜衍生物(沃伯格醛、聚莪术二醛和伊瓦林)、查耳酮类(地衣查耳酮A)、甾体皂苷(薯蓣皂苷)、黄酮类(黄芩素)、生物碱(瓦尔特碱)、大环双苄基(里卡丁D)和大麻素(大麻二酚)表现出活性。上述化合物作用于生物膜的形成和/或成熟生物膜。总之,植物制剂和化合物对该属具有抗生物膜活性。鉴于此,它们可能是抗真菌药物的一种有前景的替代品。